TCL Archive DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money August 31, 1979
TCL Archive NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients August 12, 1983
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014